Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 9,999 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jul 13, 2026 · Filed Jul 13, 2026

On Jul 13, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 9,999 Oruka Therapeutics, Inc. shares at an average US$84.63 for US$846K under a trading plan, leaving 15,312 shares. Filed Jul 13, 2026 (Form 4).

Sold
9,999 shares
Price
US$84.63 average (US$83.07 to US$85.63)
Value
US$846K
Holding after
15,312 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Senior Vice President, Finance

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 13, 2026Common StockOption exercise8,541US$12.5023,853Direct
Jul 13, 2026Common StockOption exercise1,458US$34.3925,311Direct
Jul 13, 2026Common StockSale300US$83.0725,011Direct
Jul 13, 2026Common StockSale3,743US$84.2621,268Direct
Jul 13, 2026Common StockSale5,656US$84.9015,612Direct
Jul 13, 2026Common StockSale300US$85.6315,312Direct

Source

View original at SEC

Related